Objective-To compare neutron treatment and megavoltage (photon) radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
The five year survival rate was 24% after treatment with neutrons (20/85) and 34% after treatment with photons (27/80). The actuarial 10 year survival rates were 14% and 30% respectively (p=007, log rank test). The survival rate without local disease at five years was 19% (16/85) (95% confidence interval 11% to 27%) for patients treated with neutrons and 30% (24/80) (20% to 40%) for those treated with photons. Figure 1 shows the actuarial cause specific survival rates up to 10 years (p=0 35, log rank test).
In Discussion There is no evidence in this study of a therapeutic advantage for treatment with neutrons. Tumour control rates and cause specific survival rates were similar in the two groups. Control of tumours after photon treatment (45%) agreed with the expected results used in the design of the trial (40%), but control after neutron treatment (44%) did not reach that predicted by the study at Hammersmith Hospital. The late recurrence of a tumour in one patient and apparent sarcoma in another in the irradiated area in the group treated with neutrons are unusual. The diagnosis of soft tissue sarcoma is a cause for concern as it may be related to the treatment using high linear energy transfer neutrons.
Although the overall rate of necrosis was not significantly worse in the patients treated with neutrons, a significant difference in mortality related to treatment was seen. Despite giving a lower dose of neutrons than that at Hammersmith Hospital we also found a high mortality related to treatment, although it 
